RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Chenguang Biotech Group Co Stock

Chenguang Biotech Group Co Net Income 2024

Chenguang Biotech Group Co Net Income

171.16 M CNY

Ticker

300138.SZ

ISIN

CNE100000WC5

In 2024, Chenguang Biotech Group Co's profit amounted to 171.16 M CNY, a -64.32% increase from the 479.72 M CNY profit recorded in the previous year.

The Chenguang Biotech Group Co Net Income history

YEARNET INCOME (undefined CNY)
2026e360.22
2025e273.68
2024e171.16
2023479.72
2022434.03
2021351.51
2020271.5
2019193.6
2018145.3
2017142.8
201692.5
201568.9
201422.4
201310.5
201258.9
201175
201063.5
200948.8
200838.5
200711.7

Chenguang Biotech Group Co Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Chenguang Biotech Group Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Chenguang Biotech Group Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Chenguang Biotech Group Co’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Chenguang Biotech Group Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Chenguang Biotech Group Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Chenguang Biotech Group Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Chenguang Biotech Group Co’s growth potential.

Chenguang Biotech Group Co Revenue, EBIT and net profit per share

DateChenguang Biotech Group Co RevenueChenguang Biotech Group Co EBITChenguang Biotech Group Co Net Income
2026e8.45 B undefined693.05 M undefined360.22 M undefined
2025e7.57 B undefined569.38 M undefined273.68 M undefined
2024e6.99 B undefined363.05 M undefined171.16 M undefined
20236.87 B undefined520.4 M undefined479.72 M undefined
20226.3 B undefined473.52 M undefined434.03 M undefined
20214.87 B undefined410.4 M undefined351.51 M undefined
20203.91 B undefined369.4 M undefined271.5 M undefined
20193.27 B undefined254.1 M undefined193.6 M undefined
20183.06 B undefined181.7 M undefined145.3 M undefined
20172.77 B undefined160.8 M undefined142.8 M undefined
20162.14 B undefined90.4 M undefined92.5 M undefined
20151.27 B undefined63.2 M undefined68.9 M undefined
20141.21 B undefined30.5 M undefined22.4 M undefined
20131.19 B undefined36.1 M undefined10.5 M undefined
2012951.3 M undefined49.4 M undefined58.9 M undefined
20111.07 B undefined82.8 M undefined75 M undefined
2010584.1 M undefined77 M undefined63.5 M undefined
2009414 M undefined63.2 M undefined48.8 M undefined
2008319.6 M undefined51 M undefined38.5 M undefined
2007152.5 M undefined21.2 M undefined11.7 M undefined

Chenguang Biotech Group Co stock margins

The Chenguang Biotech Group Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Chenguang Biotech Group Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Chenguang Biotech Group Co.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Chenguang Biotech Group Co's sales revenue. A higher gross margin percentage indicates that the Chenguang Biotech Group Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Chenguang Biotech Group Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Chenguang Biotech Group Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Chenguang Biotech Group Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Chenguang Biotech Group Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Chenguang Biotech Group Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Chenguang Biotech Group Co Margin History

Chenguang Biotech Group Co Gross marginChenguang Biotech Group Co Profit marginChenguang Biotech Group Co EBIT marginChenguang Biotech Group Co Profit margin
2026e11.67 %8.2 %4.26 %
2025e11.67 %7.52 %3.61 %
2024e11.67 %5.19 %2.45 %
202311.67 %7.57 %6.98 %
202213.45 %7.52 %6.89 %
202114.37 %8.42 %7.21 %
202016.17 %9.44 %6.94 %
201917.59 %7.78 %5.93 %
201814.12 %5.93 %4.74 %
201712.51 %5.8 %5.15 %
201613.67 %4.22 %4.32 %
201513.73 %4.99 %5.44 %
201410.66 %2.53 %1.86 %
201312.29 %3.04 %0.89 %
201215.97 %5.19 %6.19 %
201114.99 %7.73 %7 %
201021.01 %13.18 %10.87 %
200924.59 %15.27 %11.79 %
200823.25 %15.96 %12.05 %
200723.61 %13.9 %7.67 %

Chenguang Biotech Group Co Aktienanalyse

What does Chenguang Biotech Group Co do?

Chenguang Biotech Group Co Ltd is a professional manufacturer of high-quality biological products. The company is headquartered in China and was founded in 2009. Since then, the company has quickly become one of the leading companies in the biotechnology products industry. Chenguang Biotech Group Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Chenguang Biotech Group Co's Profit Margins

The profit margins of Chenguang Biotech Group Co represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Chenguang Biotech Group Co's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Chenguang Biotech Group Co's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Chenguang Biotech Group Co's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Chenguang Biotech Group Co’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Chenguang Biotech Group Co stock

How much profit has Chenguang Biotech Group Co made this year?

Chenguang Biotech Group Co has made 171.16 M CNY this year.

How has the profit developed compared to last year?

The profit has increased by -64.32% compared to last year fallen

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Chenguang Biotech Group Co publish its earnings?

Chenguang Biotech Group Co publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Chenguang Biotech Group Co?

The profits of Chenguang Biotech Group Co are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Chenguang Biotech Group Co?

You can learn more about the earnings of Chenguang Biotech Group Co by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Chenguang Biotech Group Co pay?

Over the past 12 months, Chenguang Biotech Group Co paid a dividend of 0.16 CNY . This corresponds to a dividend yield of about 1.81 %. For the coming 12 months, Chenguang Biotech Group Co is expected to pay a dividend of 0.18 CNY.

What is the dividend yield of Chenguang Biotech Group Co?

The current dividend yield of Chenguang Biotech Group Co is 1.81 %.

When does Chenguang Biotech Group Co pay dividends?

Chenguang Biotech Group Co pays a quarterly dividend. This is distributed in the months of May, July, June, July.

How secure is the dividend of Chenguang Biotech Group Co?

Chenguang Biotech Group Co paid dividends every year for the past 16 years.

What is the dividend of Chenguang Biotech Group Co?

For the upcoming 12 months, dividends amounting to 0.18 CNY are expected. This corresponds to a dividend yield of 2.02 %.

In which sector is Chenguang Biotech Group Co located?

Chenguang Biotech Group Co is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von Chenguang Biotech Group Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Chenguang Biotech Group Co from 6/13/2024 amounting to 0.13 CNY, you needed to have the stock in your portfolio before the ex-date on 6/13/2024.

When did Chenguang Biotech Group Co pay the last dividend?

The last dividend was paid out on 6/13/2024.

What was the dividend of Chenguang Biotech Group Co in the year 2023?

In the year 2023, Chenguang Biotech Group Co distributed 0.13 CNY as dividends.

In which currency does Chenguang Biotech Group Co pay out the dividend?

The dividends of Chenguang Biotech Group Co are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Chenguang Biotech Group Co

Our stock analysis for Chenguang Biotech Group Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Chenguang Biotech Group Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.